Ion trap tandem mass spectrometry at the whole protein level identified N-terminally acetylated thymosin beta4 in a human lung cancer cell line.
In plain wordsIn lab tests on a human lung cancer cell line, a mass spectrometry method identified thymosin beta4.
- Peptide
- Thymosin beta-4 (human)
- Outcome
- Not applicableIdentification of N-terminally acetylated thymosin beta4 by ion trap tandem mass spectrometry
- Study
humann: not reported in source
human lung cancer cell line- Outcome group
- Receptor activity and mechanism · Pharmacology
Source sentences
N-Terminally acetylated thymosin beta4, a species implicated for use as a cancer biomarker, was identified in a human lung cancer cell line using ion trap tandem mass spectrometry at the whole protein level.
1 context sentence(design, population, supporting numbers)
Ion-ion proton transfer reactions were used for parent ion concentration/manipulation and to simplify interpretation of product ion spectra.
In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).